EIN 13-3174839

The Glaucoma Foundation

IRS 501(c) type
501(c)(3)
Num. employees
5
Year formed
1984
Most recent tax filings
2023-12-01
Description
The Glaucoma Foundation is an international not-for-profit organization with a mission to eradicate glaucoma, the leading cause of preventable blindness. The foundation's strategy involves raising public awareness about the necessity of routine eye exams and awarding grants-in-aid for glaucoma research in disciplines such as optic nerve rescue and restoration, neuroprotectants, and reversing dysfunction of damaged retinal ganglion cells. The foundation is located in New York, NY.
Total revenues
$4,763,086
2023
Total expenses
$2,878,347
2023
Total assets
$13,946,604
2023
Num. employees
5
2023

Program areas at The Glaucoma Foundation

See schedule oeducation:1) multiple webinars: what do cold hands have to do with Glaucoma? The promise of optic nerve regeneration;the body-eye relationship how to save The sight of patients with Glaucoma while minimizing adverse reaction from eye drops;insights into Glaucoma & women's health: exploring The impact of menopause and visual function;glaucoma and lifestyle.2) The 28th annual optic nerve rescue and restoration think tank "a patient-centric approach while incorporating The latest science" Glaucoma data integration:overview of databases available to advance Glaucoma knowledge;lessons learned about Glaucoma from The uk biobank;poag genomic architecture;a 360-degree biomedical profile of health: lessons from cardiovascular disease.3) drug re-purposing in glaucoma:insulin signaling and;metformin and glaucoma;glp-1r agonists and glaucoma;4) overview of Glaucoma neuroprotection agents:why do we not have a neuroprotection agent for glaucoma?how can ai help facilitate randomized clinical trials in neuroprotection?5) sex hormones and glaucoma:the role of sex hormones in The pathogenesis of open-angle Glaucoma: evidence from epidemiological studies;estrogen signaling pathways in glaucoma;the biomechanical argument that estrogen plays a role in glaucoma;6) non-iop factors of importance in glaucoma:diet and glaucoma;hypertension, antihypertensive drugs and glaucoma;the impact of Glaucoma on activities of daily living.7) what can tgf do to help patients, researchers, and eyecare providers tackle Glaucoma? :what is The Glaucoma Foundation doing now?what do patients want to see in Glaucoma research?8) start with The younginfo session on Glaucoma for middle and high school students;in coordination with The stem institute at The city college of new york.9) newsletters: tgf produced six electronic newsletters that were distributed to more than 16,000 households. Tgf's quarterly printed newsletters were available for constituents who do not use computers or who prefer to read paper documents. Newsletters include interviews with doctors, researchers, and patients. They cover topics such as advancements in diagnosis and treatment, perspectives on care, and personal stories of living with The disease.
See schedule omedical research:1) genetic predisposition and ophthalmic outcomes;2) optic nerve regeneration;3) using artificial intelligence to reveal blood pressure's role in Glaucoma progression;4) ee-purposing an "old" drug for a new indication: elucidating The peripheral and central effects of glucagon-like peptide 1 receptor agonists to treat Glaucoma; 5) search for functional loxl1 risk alleles with bit-starr;6) vascular genotype-phenotype association in primary open-angle glaucoma;7) investigating The role of impaired mitochondrial dynamics in exfoliation glaucoma;8) uncovering The potential of pericytes as therapeutic targets for glaucoma;9) nicotinamide and pyruvate for neuroenhancement in open-angle Glaucoma: a phase 2 randomized clinical trial.

Grants made by The Glaucoma Foundation

GranteeGrant descriptionAmount
Regents Univ of CaliforniaMedical Research$189,750
Icahn School of Medicine at Mount SinaiMedical Research$100,000
Georgia Tech Research CorporationMedical Research$60,000
...and 5 more grants made

Who funds The Glaucoma Foundation

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
The Gerald and Daphna Cramer FoundationCharitable$300,000
Mahadeva Family FoundationGeneral Purposes$70,000
The Allergan FoundationUnrestricted Operations Support$50,000
...and 32 more grants received totalling $522,559

Personnel at The Glaucoma Foundation

NameTitleCompensation
Elena SturmanPresident and Chief Executive Officer$350,733
Andrea SteeleDirector of Operations
Angela CooleyDirector of Fundraising
Cly FowkesDirector of Special Projects$131,902
Elena Cly FowkesDirector of Special Project$132,623
...and 6 more key personnel

Financials for The Glaucoma Foundation

RevenuesFYE 12/2023
Total grants, contributions, etc.$2,676,417
Program services$0
Investment income and dividends$386,991
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$1,699,678
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$4,763,086

Form 990s for The Glaucoma Foundation

Fiscal year endingDate received by IRSFormPDF link
2023-122024-07-10990View PDF
2022-122023-08-14990View PDF
2021-122022-06-28990View PDF
2020-122021-06-17990View PDF
2019-122021-01-21990View PDF
...and 9 more Form 990s
Data update history
August 26, 2024
Posted financials
Added Form 990 for fiscal year 2023
August 26, 2024
Updated personnel
Identified 3 new personnel
August 10, 2024
Received grants
Identified 5 new grant, including a grant for $10,500 from Glaucoma Science and Education Foundation
May 18, 2024
Received grants
Identified 5 new grant, including a grant for $300,000 from The Gerald and Daphna Cramer Foundation
October 24, 2023
Received grants
Identified 2 new grant, including a grant for $20,000 from Longhill Charitable Foundation
Nonprofit Types
Grantmaking organizationsDisease research fundraisersDisease-focused nonprofitsCharities
Issues
HealthDiseases and disorders
Characteristics
Provides grantsConducts researchOperates internationallyNational levelEndowed supportGala fundraisersTax deductible donationsAccepts online donations
General information
Address
80 Maiden LN 700
New York, NY 10038
Metro area
New York-Newark-Jersey City, NY-NJ-PA
County
New York County, NY
Website URL
glaucomafoundation.org/ 
Phone
(212) 651-1900
Facebook page
The.Glaucoma.Foundation 
Twitter profile
@tgf_glaucoma 
IRS details
EIN
13-3174839
Fiscal year end
December
Taxreturn type
Form 990
Year formed
1984
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
G40: Diseases of Specific Organs
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent
California AB-488 details
AB 488 status
May Operate or Solicit for Charitable Purposes
Charity Registration status
Current
FTB status revoked
Not revoked
AG Registration Number
107968
FTB Entity ID
2012578
AB 488 data last updated ("as-of") date
2024-11-06
Free account sign-up

Want updates when The Glaucoma Foundation has new information, or want to find more organizations like The Glaucoma Foundation?

Create free Cause IQ account